European Injectable Drug Delivery Market worth $207.3 Billion by 2020 - PowerPoint PPT Presentation

Loading...

PPT – European Injectable Drug Delivery Market worth $207.3 Billion by 2020 PowerPoint presentation | free to download - id: 7920c2-MDA3Y



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

European Injectable Drug Delivery Market worth $207.3 Billion by 2020

Description:

The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. – PowerPoint PPT presentation

Number of Views:11

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: European Injectable Drug Delivery Market worth $207.3 Billion by 2020


1
MarketsandMarkets Presents
European Injectable Drug Delivery Market worth
207.3 Billion by 2020
2
  • The "European Injectable Drug Delivery Market By
    Formulations Liposomes, Microspheres,
    Nanoparticles, Devices Disposables Reusable,
    Fillable Prefilled, Pen, Needle Free Auto
    Injectors Therapeutics Diabetes Oncology -
    Forecasts to 2020 "analyzes and studies the major
    market drivers, restraints, and opportunities in
    Germany, France, U.K., Spain, Italy, Russia and
    Rest of Europe (RoE).
  • Browse 143 market data tables with 25 figures
    spread through 333 pages and in-depth TOC on
    "European Injectable Drug Delivery Market By
    Formulations Liposomes, Microspheres,
    Nanoparticles, Devices Disposables Reusable,
    Fillable Prefilled, Pen, Needle Free Auto
    Injectors Therapeutics Diabetes Oncology -
    Forecasts to 2020"
  • http//www.marketsandmarkets.com/Market-Reports/e
    uropean-injectable-drug-delivery-market-1205.html

3

Early buyers will receive 10 customization on
Reports.
4
  • This report studies the European injectable drug
    delivery technologies market over the forecast
    period of 2015 to 2020.
  • The European injectable drug delivery market is
    expected to reach 207.3 Billion by 2020 from
    114.7 Billion in 2015, growing at a CAGR of
    12.6 from 2015 to 2020.The injectable drug
    delivery technologies market is broadly
    categorized into two major segments, namely,
    devices technologies and formulation
    technologies. Based on product, the injectable
    drug delivery devices technologies market is
    further categorized as conventional injection
    devices, self-injection devices, and others
    (micro needles, Nano needles and blunt needle
    injections), while the injectable drug delivery
    formulation technologies market is categorized
    into conventional drug delivery formulations and
    novel drug delivery formulations. The
    conventional injection devices segment accounted
    for the largest share of the European injectable
    drug delivery technologies market in 2015.

5
  • The growth of the injectable drug delivery
    technologies market is primarily triggered by
    favorable reimbursement policies on injectable
    drugs and devices, technological advancements,
    surge of biologics in pharmaceutical markets,
    rising incidences of cancer and diabetes in
    Europe, and improving patient compliance. The
    evolving opportunities in this market for
    manufacturers include development of biosimilars
    in pharmaceutical markets and focus of
    pharmaceutical manufacturers towards emerging
    markets such as Spain, Russia, Denmark, Ireland
    and others. However, factors such as needle-stick
    injuries and infections and development of
    alternate delivery methods are restraining the
    growth of the market.

6
  • The major geographic markets covered in this
    report are North Germany, France, U.K., Spain,
    Italy, Russia and Rest of Europe (RoE). Germany
    dominates the market, followed by France. The
    other European regions of Spain, Italy and Russia
    and RoE show high export potential for plastic
    syringes and needle, favorable reimbursement
    policies for injectable devices, rising support
    for generics market and increasing expenditure in
    healthcare sector, favorable environment for
    research and development, and growth in diabetic
    expenditures. The key players in this market are
    Becton Dickinson Co. (U.S.), Baxter
    International, Inc. (U.S.), Novo Nordisk A/S
    (Denmark), Ypsomed Holding AG (Switzerland), Eli
    Lily Co. (U.S.), Gerresheimer AG (Germany),
    Sanofi (France), West Pharmaceutical Services,
    Inc. (U.S.), Haselmeier GmbH (Germany), Owen
    Mumford, Ltd. (U.K.) and others.

7
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
8
Contact Us
Mr. RohanMarkets and Markets  UNIT no 802,
Tower no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, India 1-888-600-6441
FREEEmail sales_at_marketsandmarkets.com Marketsan
dMarkets Bloghttp//twitter.com/marketsmarkets
http//www.linkedin.com/company/marketsandmarkets
About PowerShow.com